Here are five things to know:
1. Ms. Cote has more than 14 years of experience in stem cell technology, surgical implants and regenerative therapies.
2. Already Ms. Cote has an award-winning sales career and her experience includes technical expertise and strategic developing focused on a biologics portfolio for ChoiceSpine.
3. Prior to her current position, Ms. Cote was vice president of biologics with Amendia and biologics regional vice president of Orthofix.
4. Ms. Cote earned her degree in applied biology with a focus in microbiology from The Georgia Institute of Technology.
More articles on orthopedic devices:
NuVasive names Joan Stefslien EVP, general counsel: 5 key notes
Zimmer Biomet, SI-BONE, Amendia & more: 10 key notes
Global market for cervical total disc replacement devices to reach $1.75B by 2021
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
